Alpha1-Antitrypsin
Test ID:
702765
CPT code:
82103
Synonyms:
Acute Phase Proteins
Alpha1-Protease Inhibitor
Clinical Use:
Detection of hereditary decreases in the production of α1-antitrypsin (α1AT). Decreased or nearly absent levels of α1AT can be a factor in chronic obstructive lung disease and liver disease. An increased prevalence of non-MM phenotypes is found with cryptogenic cirrhosis and with CAH. Cirrhosis in a child should raise consideration of α1AT deficiency or Wilson’s disease. Diagnosis of inflammatory states, if elevated (eg, rheumatoid arthritis, bacterial infection, vasculitis, neoplasia).
Additional Test Information:
Should be run when α1-globulin in serum protein electrophoresis is low or when two bands are seen in the α1-region. Heterozygous patients exhibit AAT levels which are commonly about 60% of normal. Homozygous recessive α1AT patients exhibit levels at about 10% of normal. Phenotyping is desirable on patients with low values and on all patients being worked up for AAT-deficient liver disease. Most pathologic is homozygous state ZZ. An M null genotype will have phenotype as MM but low serum level. AAT is one of the alpha-globulins, which together are called “acute phase reactants.” These rise rapidly, but nonspecifically, in response to inflammatory insults.
Specimen Type:
Serum or plasma
Requested Volume:
1 mL
Minimum Volume:
0.5 mL (Note: This volume does not allow for repeat testing.)
Container Type:
Red-top tube, gel-barrier tube, lavender-top (EDTA) tube, or green-top (heparin) tube
Collection:
Separate serum or plasma from cells.
Storage Instructions:
Maintain specimen at room temperature.
Rejection Criteria
Chylous serum
Return Back to Test Directory
MCI Diagnostic
Providing top patient care with fast results.
Hours of Operation
Mon - Sat: 7 AM-11 PM
Sun: 7 AM-3 PM
COVID-19 Drive-Thru Hours
Mon-Fri: 9 AM-6 PM
Federal Holidays - CLOSED
More Information - Click Here
Government Contract
DUNS # 125722608
Cage Code: 3FPQ3
COVID-19
COVID-19 Fee & Pricing